These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 6223451)
1. Reply to Dr. Edwin B. McDaniel. Exaggerated claims of depo-provera safety. Minkin SF Women Health; 1981; 6(1-2):125-9. PubMed ID: 6223451 [TBL] [Abstract][Full Text] [Related]
2. The long-term growth and development of children exposed to Depo-Provera during pregnancy or lactation. Pardthaisong T; Yenchit C; Gray R Contraception; 1992 Apr; 45(4):313-24. PubMed ID: 1387602 [TBL] [Abstract][Full Text] [Related]
3. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
4. Depo provera in perspective. McGoldrick IA P N G Med J; 1981 Dec; 24(4):274-9. PubMed ID: 6461984 [TBL] [Abstract][Full Text] [Related]
5. Depo-Provera -- proving its innocence. Choudhury IR Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187 [TBL] [Abstract][Full Text] [Related]
6. A case for concern? Gartland A Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288 [TBL] [Abstract][Full Text] [Related]
7. FDA gives final approval to Depo amid concerns over safety, cost and coercion. Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620 [TBL] [Abstract][Full Text] [Related]
8. Depo-Provera: a critical analysis. Minkin S Women Health; 1980; 5(2):49-69. PubMed ID: 6451987 [TBL] [Abstract][Full Text] [Related]
9. Depo-Provera use in an Australian metropolitan practice. Fraser IS; Dennerstein GJ Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553 [TBL] [Abstract][Full Text] [Related]
10. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related]
11. What is breast cancer risk with Depo-Provera? Contracept Technol Update; 1992 Jan; 13(1):15-6. PubMed ID: 12343459 [TBL] [Abstract][Full Text] [Related]
13. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. Dennerstein GJ J Reprod Med; 1986 Sep; 31(9):801-3. PubMed ID: 2945926 [TBL] [Abstract][Full Text] [Related]
14. Some effects of depo-medroxyprogesterone acetate (DMPA): observations in the nursing infant and in the long-term user. Dahlberg K Int J Gynaecol Obstet; 1982 Feb; 20(1):43-8. PubMed ID: 6126406 [TBL] [Abstract][Full Text] [Related]
15. Depo-Provera: an injectable contraceptive. Wigington S Nurs Times; 1981 Oct 14-20; 77(42):1794-8. PubMed ID: 6458020 [TBL] [Abstract][Full Text] [Related]